Osteogenesis Imperfecta Research
In the field of osteogenesis imperfecta (OI), the National Institutes of Health Clinical Center has been at the forefront of conducting extensive research and clinical trials. These trials focus on exploring innovative treatment strategies to address this genetic disorder. The research includes investigating the potential of new drugs, growth hormone treatments, and cell or bone marrow transplants as possible therapeutic options.
Currently, there are several pharmaceuticals in advanced stages of testing, indicating promising developments in the treatment of OI. The research efforts are ongoing, with scientists committed to further understanding the effectiveness of these treatments on different types of OI caused by dominant or recessive genes.
Support for Osteogenesis Imperfecta (OI)
Dealing with a diagnosis of osteogenesis imperfecta (OI) can be mentally and emotionally challenging for individuals and their families. However, there are various forms of support available to help them navigate through this journey. Support groups, individual counseling, and active involvement in organizations dedicated to living with and managing OI can provide invaluable assistance. Additionally, online groups, podcasts, and books offer further support and resources for those affected by this condition.